InvestorsHub Logo
Followers 0
Posts 25
Boards Moderated 0
Alias Born 05/19/2017

Re: AntonChigurh post# 2236

Saturday, 05/20/2017 11:35:26 AM

Saturday, May 20, 2017 11:35:26 AM

Post# of 6315
Wow...*slow clap*. Many thanks for the informative breakdown, buckos. I had surface knowledge of some of these aspects, along with gut feelings, but it's nice to have a detailed, layered sheet of points in front of me. I'll certainly be bookmarking Anton's reply, but thank you to everyone else as well.

InMed does do a good job of selling the "sex appeal" of their supposed uniqueness, but when verbally discussing their biosynthesis process with friends, I couldn't help but wonder why the hell other biotechs would use dated and grossly inefficient techniques for extraction if this was public knowledge. It's also curious that InMed suddenly has all the valuable information, given that UofMiss has been studying the field for decades.

My gut plan was to score a couple quick hits off them, and then settle into a long play with the more secure Nemus...so thank you for providing me with some logical backing to that.

PS: shoutout to Anton as a fellow young Canadian! Congrats on doubling your investment in InMed when you did, I missed the boat there but hope to celebrate even heartier gains with Nemus as it progresses.

Happy weekend, fellas.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SKYE News